Clinical Trial Update: UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial update for intravenous busulfan (Busulfex) in patients with multiple myeloma; the study was terminated and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Busulfex (busulfan)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-06-20